Navigation Links
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
Date:10/24/2007

very serious form of skin cancer that accounts for the majority of skin-cancer related deaths each year. The number of people diagnosed with melanoma is rapidly increasing with more than 62,000 new cases expected to be diagnosed in the U.S. during 2007. While the chance of developing melanoma increases with age, it remains one of the most common cancers in young adults. This type of cancer begins in specific cells in the skin and can metastasize, or spread, throughout the body to many organ systems. Patients with Stage IV metastatic melanoma typically have a median survival of less than nine months despite current standard therapies, underscoring the need for novel therapeutics to address the unmet medical need in this patient population.

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer including belinostat and CR011-vcMMAE. By leveraging drug development strengths cultivated over the years, CuraGen expects to make a difference by advancing its promising therapeutics to address the unmet medical needs of cancer patients. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.

Safe Harbor

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to CuraGen's CR011-vcMMAE program, including the potential of CR011-vcMMAE for metastatic melanoma and the progress and timeframe of clinical trials of CR011-vcMMAE may constitute forward-looking statements within the mea
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Research and Markets  has announced the addition ... & Technologies" report to their offering. ... or you wish to expand your product line, you,ll ... The authors know you want to make effective product ... generate improved revenues and take market share from your ...
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and Chinese Particulate Respirators Industry Report 2014" ... Global and Chinese Particulate Respirators Industry Report 2014 is ... of the global particulate respirators industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
(Date:8/22/2014)... Ill. , Aug. 22, 2014  Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... today that William E. Saxelby , its President ... President and Chief Executive Officer and as a member ... 15, 2014.  He will be replaced on an interim ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Global and Chinese Particulate Respirators Industry Report 2014 2Landauer, Inc. Announces Executive Management Change 2
... 29, 2011 A woman,s face tells her story but ... surgery, fillers, lasers and more, the quest continues for new ...  According to the new Face Forward survey commissioned by ... aesthetics cleared by the FDA with a non-invasive lift indication), ...
... LLC, a private biotechnology company focused on the treatment ... announced publication of promising preclinical data demonstrating that the ... diabetes in a mouse model.  The results of the ... of Rejuvenation Research and available currently ...
Cached Medicine Technology:What Would Women Give Up for a More Youthful Face? 2What Would Women Give Up for a More Youthful Face? 3Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 2Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 3Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 4
(Date:8/22/2014)... August 22, 2014 Japantown Dental is ... new teeth whitening technique. Air polishing is a technique ... , Dark teeth can be caused by a number ... stains and internal stains. External stains include coffee, wine, ... caused by certain medications, such as tetracycline, and direct ...
(Date:8/22/2014)... 2014 Recently, iFitDress.com, a well-known wedding ... of discounted wedding gowns . In addition to ... these new products are provided with low shipping fees. ... to unveil the new wedding gowns. In our online ... for ladies to choose from. What’s more, all of ...
(Date:8/22/2014)... Amy Norton HealthDay Reporter ... growing number of Americans on work disability chronically use ... Researchers found that between 2007 and 2011, about 44 ... were prescribed narcotic painkillers each year. And the percentage ... 2007 to 23 percent in 2011. Experts ...
(Date:8/22/2014)... Health New Orleans School of Nursing was awarded ... increase access to advanced nursing education and patient ... well as veterans. The Health Resources and Services ... Human Services awarded the two-year grant. Scharalda Jeanfreau, ... director., The Advanced Education Nursing Traineeship (AENT) Program ...
(Date:8/22/2014)... 2014 As the controversy surrounding ... in uterine surgeries continues to grow, Bernstein Liebhard ... decided to limit coverage of uterine morcellation. According ... Cross-Blue Shield of Massachusetts will no longer cover ... as of September 1, 2014. Other insurers in ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4
... to PresentLOS ANGELES, April 27 Aviva ... that provides care and treatment to abandoned, neglected, abused and ... 28, 2009 at The SLS Hotel at Beverly Hills. ... Tracee Ellis Ross, The UXB(R) CEO, NancyJane Goldston and Johnson ...
... NJHA,s Valerie Sellers was a panelist today at an ... New York. The regional workshops, "Standards of Care During ... of Medicine initiative to support the nation,s healthcare providers ... lessons are applicable to an array of health emergencies ...
... (NYSE: NTY ) ( www.NBTY.com ), ... announced that it will web cast the presentation by Harvey ... Barclays Capital 2009 Retail And Restaurants Conference in ... to be web cast live on the Company Web site, ...
... April 27 Susan Brady of MedThink ... in the nation to become certified by the ... organization that provides advocacy and education for medical ... in-depth knowledge and expertise on best practices and ...
... declares a Public Health EmergencyHARRISBURG, Pa., April 27 ... federal officials to contain the impact of an outbreak ... declaration of a national public health emergency in the ... the public and health care providers of recommended steps ...
... health advocacy and qualityOAKLAND, Calif., April 27 ... television commercials to its Thrive advertising ... titled "Mural" and "Kabuki," reinforce Kaiser Permanente,s commitment ... the organization,s dedication to helping its members achieve ...
Cached Medicine News:Health News:Tracee Ellis Ross, NancyJane Goldston & Vicki Martin to be Honored by Aviva Family and Children's Services at The A Party 2Health News:NJHA's Sellers Serves on Institute of Medicine Preparedness Panel 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 3Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 3Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 2Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: